AEMD vs. STSS, AVGR, VERO, AFIB, TNON, UTRS, IONM, GMVDF, VVOS, and GCTK
Should you be buying Aethlon Medical stock or one of its competitors? The main competitors of Aethlon Medical include Sharps Technology (STSS), Avinger (AVGR), Venus Concept (VERO), Acutus Medical (AFIB), Tenon Medical (TNON), Minerva Surgical (UTRS), Assure (IONM), G Medical Innovations (GMVDF), Vivos Therapeutics (VVOS), and GlucoTrack (GCTK). These companies are all part of the "surgical & medical instruments" industry.
Sharps Technology (NASDAQ:STSS) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, community ranking, valuation, dividends and profitability.
Sharps Technology has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500. Comparatively, Aethlon Medical has a beta of 1.89, meaning that its share price is 89% more volatile than the S&P 500.
In the previous week, Aethlon Medical had 3 more articles in the media than Sharps Technology. MarketBeat recorded 3 mentions for Aethlon Medical and 0 mentions for Sharps Technology. Aethlon Medical's average media sentiment score of 0.94 beat Sharps Technology's score of 0.57 indicating that Sharps Technology is being referred to more favorably in the media.
2.2% of Sharps Technology shares are owned by institutional investors. Comparatively, 3.0% of Aethlon Medical shares are owned by institutional investors. 14.1% of Sharps Technology shares are owned by company insiders. Comparatively, 4.0% of Aethlon Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Aethlon Medical's return on equity of -76.10% beat Sharps Technology's return on equity.
Aethlon Medical received 215 more outperform votes than Sharps Technology when rated by MarketBeat users. However, 100.00% of users gave Sharps Technology an outperform vote while only 55.38% of users gave Aethlon Medical an outperform vote.
Aethlon Medical has a consensus target price of $10.00, indicating a potential upside of 498.80%. Given Sharps Technology's higher probable upside, analysts plainly believe Aethlon Medical is more favorable than Sharps Technology.
Sharps Technology has higher earnings, but lower revenue than Aethlon Medical.
Summary
Sharps Technology and Aethlon Medical tied by winning 6 of the 12 factors compared between the two stocks.
Get Aethlon Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AEMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Aethlon Medical Competitors List
Related Companies and Tools